Trademark Overview
On Tuesday, June 27, 2023, a trademark application was filed for SANEGENE BIO with the United States Patent and Trademark Office. The USPTO has given the SANEGENE BIO trademark a serial number of 98061878. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, October 24, 2024. This trademark is owned by Suzhou Sanegene Bio Inc.. The SANEGENE BIO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of various diseases, namely, rare {ocular, renal, muscular, metabolic, immune
system, cardiovascular, neurological and respiratory} diseases, genetic disorders, chronic liver diseases, cardiovascular diseases,
cancers, and viral infections; Chemical preparations for pharmaceutical or medical purposes, namely, oligonucleotide compounds
for use in the targeted delivery of {Ribonucleic acid interference} (RNAi) therapy; Pharmaceutical preparations for use in {injection}
for treatment of rare {ocular, renal, muscular, metabolic, immune system, cardiovascular, neurological and respiratory} diseases,
genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Chemical preparations for
pharmaceutical or medical purposes, namely, molecular nanoparticle complexes that act as a platform for the delivery of RNAbased drugs to biological cells; Drug delivery agents consisting of oligonucleotide compounds that facil...
